Vor Biopharma Inc. — Director's Dealing 2021

Feb 5, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vor Biopharma Inc. (VOR)
CIK: 0001817229
Period of Report: 2021-02-04

Reporting Person: Kassim Sadik (Chief Technology Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$1.36	2029-12-16	Common Stock (77077)		Direct
Employee Stock Option (right to buy)	$2.18	2030-03-09	Common Stock (40684)		Direct
Employee Stock Option (right to buy)	$1.90	2030-08-20	Common Stock (180882)		Direct

Footnotes

F1: 1/4th of the shares underlying the option vested on September 30, 2020, with the remainder vesting in equal monthly installments over 3 years, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date.

F2: 1/16th of the shares underlying the option vested on October 1, 2020, with the remainder vesting in equal monthly installments over 45 months, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date.